2019年癌症治疗与幸存者统计
美国癌症协会与国家癌症研究所合作,基于SEER登记处发病率与生存数据、CDC/NCHS生命统计及美国人口普查局人口预测,估算美国癌症患病情况并描述最常见癌种的治疗模式及短期、长期和晚期健康效应。2019年男性最常见三种癌为前列腺癌(3,650,030)、结直肠癌(776,120)和皮肤黑色素瘤(684,470),女性为乳腺癌(3,861,520)、子宫体癌(807,860)和结直肠癌(768,650)。
要点
- 男性最常见幸存癌种为前列腺癌、结直肠癌和皮肤黑色素瘤。
- 女性最常见幸存癌种为乳腺癌、子宫体癌和结直肠癌。
核心结论
- 美国癌症幸存者数量持续增加,源于人口增长与老龄化以及早期检测和治疗进步。
研究设计与样本
- 美国癌症协会与国家癌症研究所每3年合作,利用SEER登记处发病与生存数据、CDC/NCHS生命统计及美国人口普查局人口预测估算美国癌症患病情况。
- 基于国家癌症数据库信息呈现最常见癌种当前治疗模式,并简要描述癌症及治疗相关的短期、长期和晚期健康效应。
主要发现
- 2019年男性最常见三种癌为前列腺癌(3,650,030)、结直肠癌(776,120)和皮肤黑色素瘤(684,470)。
- 2019年女性最常见三种癌为乳腺癌(3,861,520)、子宫体癌(807,860)和结直肠癌(768,650)。
- 超过一半(56%)幸存者在过去10年内诊断,近三分之二(64%)年龄≥65岁。
关键数值与推荐
- 2019年男性前列腺癌幸存者3,650,030例、结直肠癌776,120例、皮肤黑色素瘤684,470例。
- 2019年女性乳腺癌幸存者3,861,520例、子宫体癌807,860例、结直肠癌768,650例。
- 幸存者中56%诊断于过去10年内,64%年龄≥65岁。
临床怎么用
- 有癌症史人群具有独特医疗和心理社会需求,需随访照护提供者主动评估和管理。
- 已有越来越多工具可帮助患者、照护者和临床医生应对癌症幸存各阶段,但仍需进一步循证资源以优化照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment. To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau. Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types. Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described. More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone. The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females. More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers. Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.
引用
- Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019. PMID: 31184787. doi:10.3322/caac.21565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。